Response to androgen therapy in patients with dyskeratosis congenita. Khincha PP, Wentzensen IM, Giri N, Alter BP, Savage SA. Br J Haematol. 2014 May;165(3):349-57

Recent Posts

1- Telomeres Connect Us Together for a Brighter Future

Highlighting the Importance of Telomere Biology Disorder Month November marks Telomere Biology Disorder (TBD) Awareness…

1 week ago

Rare Diseases Day – 28/02

Exploring the Power of Rare - Welcome to the World of Rare Diseases! Although we…

2 years ago

Telomere & Preventive Medicine

Could preventive medicine be as simple as a blood test? Some diseases can be overlooked…

2 years ago

Telomere testing 101: what is behind this door?

Telomeres?? Telomere length?? What in the world! These are the typical reactions among the ones…

2 years ago

Guest blog: Team Telomere launches new TBD Diagnosis and Management Guidelines

The second edition Telomere Biology Disorders: Diagnosis and Management Guidelines have been officially published. This…

3 years ago

Guest blog: Jeni shares her experience with short telomeres for Rare Disease Day

To help raise awareness of rare disease dyskeratosis congenita, and other telomere biology disorders caused…

3 years ago